Pelex
Pelex is developing a biofeedback device, consisting of a garment with embedded sensors and a downloadable software program, allowing users to perform biofeedback anywhere. Pelex Team: Jeremy Wiygul
Read MoreMyophonX
MyophonX is an individually tailored wearable device that applies machine learning to silent articulation to restore speech in patients with limited phonation capacity. MyophonX Team: Anais Rameau, CEO Tal Herman,…
Read MoreLucerna, Inc.
At Lucerna, we are developing new sets of research tools to study and exploit RNA the same way fluorescent proteins did for the protein field. Lucerna Team: Karen Wu
Read MoreUnicrobe
We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO…
Read MoreImmuneTarget, Inc.
Our mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases. ImmuneTarget, Inc. Team: Hsiou-Chi Liou Samedy Ouk
Read MoreBrainWire
BrainWire is a software based on brain MRI that can predict the future risk and patterns of Alzheimer’s and dementia, commericialized as an out-of-pocket elective procedure. BrainWire Team: Ashish Raj
Read MoreMedImageMetric
We develop image processing software to assist neurosurgeons performing image guided surgery. MedimageMetric Team: Tian Liu
Read MoreLumidyne Technologies
Lumidyne Technologies–Commercialization of next-generation fluorescent probes with enhanced brightness and photostability across the visible spectrum. Lumidyne Technologies Team: Roger Altman Scott Blanchard
Read MoreImmunovENT
ImmunovENT re-invents allergy diagnostics with the Local Allergy Mucosal Brush (LAMB) Test, which identifies local antigen-specific igE not found by skin or blood testing. ImmunovENT Team: Kate Rochlin
Read MoreSveikatal
Sveikatal, is focused on the management of oral cancer using a novel retinoid therapy, which acts through pathways controlled by Vitamin A and complements current therapies. Sveikatal Team: John Wagner,…
Read More